HJM-561

N/A

Report date: 2026/01/14 17:56:35
NME

Base Information

Drug NameHJM-561
Drug Alias NameHJM-561
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionEGFR C797S inhibitors
TargetsEGFR C797S
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJing Medicine Technology (Shanghai) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJing Medicine Technology (Shanghai) Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A